LEUKEMIA
Clinical trials for LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new LEUKEMIA trials appear
Sign up with your email to follow new studies for LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Scientists test exercise as Anti-Aging treatment for cancer survivors
Disease control Not yet recruitingThis study aims to see if exercise and behavioral coaching can slow down accelerated aging in older adults who have survived blood cancers like leukemia and lymphoma. Researchers will enroll 180 participants aged 50+ and randomly assign them to different exercise programs to meas…
Matched conditions: LEUKEMIA
Phase: PHASE2 • Sponsor: University of Nebraska • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New family approach fights weight gain in kids who beat leukemia
Disease control Not yet recruitingThis study tests two different family-based programs designed to help children who have survived acute lymphoblastic leukemia (ALL) maintain a healthy weight. The programs involve both the child and their primary caregiver, comparing a basic educational approach with a more struc…
Matched conditions: LEUKEMIA
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Mar 27, 2026 12:40 UTC
-
Scientists test new weapon in fight against tough blood cancer
Disease control Not yet recruitingThis early-stage study aims to find a safe dose for a new three-drug combination to treat acute myeloid leukemia (AML). Researchers will add an experimental drug called eganelisib to two standard medications to see if it's safe and shows early signs of helping patients. The study…
Matched conditions: LEUKEMIA
Phase: PHASE1 • Sponsor: Jacqueline Garcia, MD • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC
-
New hope for young adults battling leukemia: testing a powerful drug combo
Disease control Not yet recruitingThis study is testing a combination of chemotherapy and an immunotherapy drug (blinatumomab) to treat a type of blood cancer called acute lymphoblastic leukemia (ALL) in adolescents and young adults. The goal is to see if this specific treatment plan is safe and effective for thi…
Matched conditions: LEUKEMIA
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC
-
New hope for tough blood cancers: early trial tests BT02
Disease control Not yet recruitingThis early-stage study aims to test the safety and early effectiveness of an investigational drug called BT02 for adults with blood cancers that have returned or not responded to previous treatments. Participants will receive BT02 through an IV every few weeks for up to two years…
Matched conditions: LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Biotroy Therapeutics • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC
-
First patients sought for trial of 'Re-Engineered' immune cells to fight advanced blood cancers
Disease control Not yet recruitingThis is a first-in-human study to test the safety and early effectiveness of a new personalized immunotherapy. It is for adults with certain advanced blood cancers (like Hodgkin lymphoma and others) that have a marker called CD30 and have come back or not responded to at least tw…
Matched conditions: LEUKEMIA
Phase: PHASE1 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Mar 02, 2026 15:27 UTC
-
Massive study launches to unravel mystery link between blood and immune system
Knowledge-focused Not yet recruitingThis study aims to understand how disorders in blood cell production are connected to various inflammatory and autoimmune diseases. Researchers will observe 5,000 adult patients who have these conditions, collecting their health information over time. The goal is to create a deta…
Matched conditions: LEUKEMIA
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC
-
Tracking the hidden toll: new system aims to protect kids after cancer
Knowledge-focused Not yet recruitingThis study aims to create and test a structured follow-up system for children and young adults who have survived blood cancers like leukemia and lymphoma. It will track 400 survivors for three years to understand the long-term health problems they face and see if a new, organized…
Matched conditions: LEUKEMIA
Sponsor: The Children's Hospital of Zhejiang University School of Medicine • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC